Literature DB >> 19841885

[Complementary medicine in oncology].

T Schnöller1, R Küfer, T Eismann, L Rinnab.   

Abstract

In cancer therapy vastly different kinds of treatment regimens, but as a rule scientifically validated and reviewed, play a central role dependent on the tumor entity. Besides the options of schoolbook medicine complementary, alternative and supportive treatment options are becoming more frequently used in routine clinical practice. Numerous concepts and agents, partly verified in studies and partly based on empirical experiences are being applied. It is our intention to give a survey of the most common agents and concepts and to point out the risks and capabilities.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19841885     DOI： 10.1007/s00120-009-2110-5

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  36 in total

Review 1.  Review of thymic hormones in cancer diagnosis and treatment.

Authors:  B Bodey; B Bodey; S E Siegel; H E Kaiser
Journal:  Int J Immunopharmacol       Date:  2000-04

Review 2.  Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review.

Authors:  Ping Yang; Jon O Ebbert; Zhifu Sun; Richard M Weinshilboum
Journal:  J Clin Oncol       Date:  2006-04-10       Impact factor: 44.544

3.  Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients.

Authors:  N Cascinelli; F Belli; L Mascheroni; L Lenisa; C Clemente
Journal:  Melanoma Res       Date:  1998-02       Impact factor: 3.599

4.  Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo.

Authors:  Tatiana Syrovets; Jürgen E Gschwend; Berthold Büchele; Yves Laumonnier; Waltraud Zugmaier; Felicitas Genze; Thomas Simmet
Journal:  J Biol Chem       Date:  2004-12-02       Impact factor: 5.157

Review 5.  Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.

Authors:  Simona Pisanti; Anna Maria Malfitano; Claudia Grimaldi; Antonietta Santoro; Patrizia Gazzerro; Chiara Laezza; Maurizio Bifulco
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-02       Impact factor: 4.690

Review 6.  Unproven methods of cancer management. Laetrile.

Authors: 
Journal:  CA Cancer J Clin       Date:  1991 May-Jun       Impact factor: 508.702

Review 7.  Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.

Authors:  F C Machado Rocha; S C Stéfano; R De Cássia Haiek; L M Q Rosa Oliveira; D X Da Silveira
Journal:  Eur J Cancer Care (Engl)       Date:  2008-07-09       Impact factor: 2.520

8.  Effect of selenite combined with chemotherapeutic agents on the proliferation of human carcinoma cell lines.

Authors:  Claudia P Schroeder; Eva M Goeldner; Kai Schulze-Forster; Christiane A Eickhoff; Peter Holtermann; Harald Heidecke
Journal:  Biol Trace Elem Res       Date:  2004       Impact factor: 3.738

9.  A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.

Authors:  C G Moertel; T R Fleming; J Rubin; L K Kvols; G Sarna; R Koch; V E Currie; C W Young; S E Jones; J P Davignon
Journal:  N Engl J Med       Date:  1982-01-28       Impact factor: 91.245

10.  Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model.

Authors:  A Thies; P Dautel; A Meyer; U Pfüller; U Schumacher
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640
View more
  1 in total

1.  1,2,3,4,6-Penta-O-galloylglucose within Galla Chinensis Inhibits Human LDH-A and Attenuates Cell Proliferation in MDA-MB-231 Breast Cancer Cells.

Authors:  Shihab Deiab; Elizabeth Mazzio; Suresh Eyunni; Oshlii McTier; Nelly Mateeva; Faisel Elshami; Karam F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-30       Impact factor: 2.629
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.